Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (511-520 of 710) with videos related to

Pageof 71
Sort By:
Oncotarget|September 9, 2017
Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertensionAurélie Hautefort, Julie Chesné, Jens Preussner, et al.
Respiratory Medicine|August 31, 2010
Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthmaPascal Chanez, Cécile Contin-Bordes, Gilles Garcia, et al.
Archives of Cardiovascular Diseases|April 9, 2025
Risk stratification in Eisenmenger syndromeEstibaliz Valdeolmillos, Athenaïs Boucly, Marc Humbert, et al.
ERJ Open Research|January 16, 2024
Outcomes and risk assessment in pulmonary veno-occlusive diseaseAthénaïs Boucly, Sabina Solinas, Antoine Beurnier, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT groupJérôme Avouac, Otylia Kowal-Bielecka, David Pittrow, et al.
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
Medicine|September 30, 2016
Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literatureSébastien Sanges, Cécile M Yelnik, Olivier Sitbon, et al.
The European Respiratory Journal|November 13, 2012
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective surveyStephanie Meyer, Vallerie V McLaughlin, Hans-Juergen Seyfarth, et al.
Cardiovascular Research|January 23, 2021
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overloadMélanie Lambert, Pedro Mendes-Ferreira, Maria-Rosa Ghigna, et al.
Comprehensive Physiology|February 7, 2026
Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary HypertensionMatthieu Leuillier, Mustapha Chelgham, Hind Messaoudi, et al.
Pageof 71

Showing results (511-520 of 710) with videos related to

Sort By:
Pageof 71
Oncotarget|September 9, 2017
Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertensionAurélie Hautefort, Julie Chesné, Jens Preussner, et al.
Respiratory Medicine|August 31, 2010
Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthmaPascal Chanez, Cécile Contin-Bordes, Gilles Garcia, et al.
Archives of Cardiovascular Diseases|April 9, 2025
Risk stratification in Eisenmenger syndromeEstibaliz Valdeolmillos, Athenaïs Boucly, Marc Humbert, et al.
ERJ Open Research|January 16, 2024
Outcomes and risk assessment in pulmonary veno-occlusive diseaseAthénaïs Boucly, Sabina Solinas, Antoine Beurnier, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT groupJérôme Avouac, Otylia Kowal-Bielecka, David Pittrow, et al.
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
Medicine|September 30, 2016
Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literatureSébastien Sanges, Cécile M Yelnik, Olivier Sitbon, et al.
The European Respiratory Journal|November 13, 2012
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective surveyStephanie Meyer, Vallerie V McLaughlin, Hans-Juergen Seyfarth, et al.
Cardiovascular Research|January 23, 2021
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overloadMélanie Lambert, Pedro Mendes-Ferreira, Maria-Rosa Ghigna, et al.
Comprehensive Physiology|February 7, 2026
Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary HypertensionMatthieu Leuillier, Mustapha Chelgham, Hind Messaoudi, et al.
Pageof 71